Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company focused on ...

New Delhi [India], October 28: The Department of Management, IMS Ghaziabad (University Courses Campus), successfully ...

She is a senior project manager for a biotechnology organisation ... each other through tough days so it never felt lonely ...

Evommune, Inc. ("Evommune"), a clinical-stage biotechnology company developing innovative therapies that target key drivers of chronic inflammatory diseases, today announced that on October 17, 2025, ...

President Donald Trump’s physician, Dr. Sean P. Barbabella, announced that after conducting a battery of tests, he found that ...

Learn more about whether AbbVie Inc. or Avidity Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, ...

Nikita Bhalerao, an Indian American researcher, has received the prestigious 2025 Rising Star Award from the National ...

The AI bull run is showing no signs of a slowdown despite the bears looking to find potential risks from every angle.

Avidity stock surges on $12B Novartis deal. Bessent unveils Fed chair finalists before year-end decision. HSBC faces $1.1B ...

Still, the recently released 2025-30 Arizona Bioscience Roadmap, as well as several academic, community and local government leaders, indicate that Arizona's 2002 investment in TGEN has lived up to ...

Here are the Seacoast Students of the Week for Oct. 27, as described by the school leaders who nominated them.

Learn more about whether Alvotech or Arcus Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.